Open Access<p>A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus</p>
Author(s) -
Dan He,
Jianhua Huang,
Zhe-yu Zhang,
Qing Du,
Weijun Peng,
Rong Yu,
Si-fang Zhang,
Shuihan Zhang,
Yuhui Qin
Publication year - 2019
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s216644
Subject(s) - pill , medicine , pharmacology , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , traditional medicine , bioinformatics , endocrinology , biology
Traditional Chinese medicine (TCM) formulations have proven to be advantageous in clinical treatment and prevention of disease. LiuWei DiHuang Pill (LWDH Pill) is a TCM that was employed to treat type 2 diabetes mellitus (T2DM). However, a holistic network pharmacology approach to understanding the active ingredients and the therapeutic mechanisms underlying T2DM has not been pursued.